164 related articles for article (PubMed ID: 37540188)
1. LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress.
Huang H; Tsui YM; Ho DW; Chung CY; Sze KM; Lee E; Cheung GC; Zhang VX; Wang X; Lyu X; Ng IO
Hepatology; 2024 Feb; 79(2):323-340. PubMed ID: 37540188
[TBL] [Abstract][Full Text] [Related]
2. LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway.
Wang J; Xiao Q; Chen X; Tong S; Sun J; Lv R; Wang S; Gou Y; Tan L; Xu J; Fan C; Ding G
Cell Death Dis; 2018 Feb; 9(2):197. PubMed ID: 29416001
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells.
Liu L; Yang Z; Xu Y; Li J; Xu D; Zhang L; Sun J; Xia S; Zou F; Liu Y
PLoS One; 2013; 8(8):e73038. PubMed ID: 24023668
[TBL] [Abstract][Full Text] [Related]
4. NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR/CYP signal axis in hepatocellular carcinoma.
Zhan Y; Zhang Z; Liu Y; Fang Y; Xie Y; Zheng Y; Li G; Liang L; Ding Y
BMC Med; 2022 Oct; 20(1):365. PubMed ID: 36258210
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance.
Nguyen GT; Green ER; Mecsas J
Front Cell Infect Microbiol; 2017; 7():373. PubMed ID: 28890882
[TBL] [Abstract][Full Text] [Related]
7. Developmental and activity-dependent expression of LanCL1 confers antioxidant activity required for neuronal survival.
Huang C; Chen M; Pang D; Bi D; Zou Y; Xia X; Yang W; Luo L; Deng R; Tan H; Zhou L; Yu S; Guo L; Du X; Cui Y; Hu J; Mao Q; Worley PF; Xiao B
Dev Cell; 2014 Aug; 30(4):479-87. PubMed ID: 25158856
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma.
Xu F; Chen J; Huang D
J Cancer; 2022; 13(1):278-289. PubMed ID: 34976189
[TBL] [Abstract][Full Text] [Related]
9. Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.
Tsui YM; Sze KM; Tung EK; Ho DW; Lee TK; Ng IO
Oncotarget; 2017 Jun; 8(24):39430-39442. PubMed ID: 28455968
[TBL] [Abstract][Full Text] [Related]
10. CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y
Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.
Chung JS; Park S; Park SH; Park ER; Cha PH; Kim BY; Chung YM; Woo SR; Han CJ; Kim SB; Suh KS; Jang JJ; Lee K; Choi DW; Lee S; Lee GY; Hahm KB; Shin JA; Kim BS; Noh KH; Kim TW; Lee KH; Yoo YD
Gastroenterology; 2012 Oct; 143(4):1084-94.e7. PubMed ID: 22749933
[TBL] [Abstract][Full Text] [Related]
12. Stable knockout of lanthionine synthase C-like protein-1 (LanCL1) from HeLa cells indicates a role for LanCL1 in redox regulation of deubiquitinating enzymes.
Downey A; Olcott M; Spector D; Bird K; Ter Doest A; Pierce Z; Quach E; Sparks S; Super C; Naifeh J; Powers A; White M; Hensley K
Free Radic Biol Med; 2020 Dec; 161():115-124. PubMed ID: 33049334
[TBL] [Abstract][Full Text] [Related]
13. Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes.
Daugaard M; Nitsch R; Razaghi B; McDonald L; Jarrar A; Torrino S; Castillo-Lluva S; Rotblat B; Li L; Malliri A; Lemichez E; Mettouchi A; Berman JN; Penninger JM; Sorensen PH
Nat Commun; 2013; 4():2180. PubMed ID: 23864022
[TBL] [Abstract][Full Text] [Related]
14. LanCL1 attenuates ischemia-induced oxidative stress by Sirt3-mediated preservation of mitochondrial function.
Xie Z; Cao BQ; Wang T; Lei Q; Kang T; Ge CY; Gao WJ; Hui H
Brain Res Bull; 2018 Sep; 142():216-223. PubMed ID: 30075199
[TBL] [Abstract][Full Text] [Related]
15. Animal models of male subfertility targeted on LanCL1-regulated spermatogenic redox homeostasis.
Huang C; Yang C; Pang D; Li C; Gong H; Cao X; He X; Chen X; Mu B; Cui Y; Liu W; Luo Q; Cheng A; Jia L; Chen M; Xiao B; Chen Z
Lab Anim (NY); 2022 May; 51(5):133-145. PubMed ID: 35469022
[TBL] [Abstract][Full Text] [Related]
16. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
[TBL] [Abstract][Full Text] [Related]
17. TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention.
Yang X; Chen GT; Wang YQ; Xian S; Zhang L; Zhu SM; Pan F; Cheng YX
Mol Med Rep; 2018 Feb; 17(2):2229-2238. PubMed ID: 29207048
[TBL] [Abstract][Full Text] [Related]
18. NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.
Sun B; Yu L; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
Cancer Sci; 2021 Jul; 112(7):2753-2769. PubMed ID: 33932069
[TBL] [Abstract][Full Text] [Related]
19. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.
Husain A; Chiu YT; Sze KM; Ho DW; Tsui YM; Suarez EMS; Zhang VX; Chan LK; Lee E; Lee JM; Cheung TT; Wong CC; Chung CY; Ng IO
J Hepatol; 2022 Aug; 77(2):383-396. PubMed ID: 35227773
[TBL] [Abstract][Full Text] [Related]
20. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
